Our mission is to advance the frontiers of immunology by applying innovative experimental techniques in genome engineering, synthetic biology, and cellular and molecular immunology—bridging these discoveries to high-need clinical areas to develop the next generation of immunotherapies.
We aim to fully leverage the innate, broad-spectrum capabilities of NK cells, whose natural role as front-line defenders positions them as powerful agents against a wide range of human diseases.
We are committed to translate our discoveries into real-world solutions that improve human health.
